NM_024753.5:c.*1105G>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024753.5(TTC21B):​c.*1105G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.239 in 151,918 control chromosomes in the GnomAD database, including 5,150 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 5150 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

TTC21B
NM_024753.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.364

Publications

2 publications found
Variant links:
Genes affected
TTC21B (HGNC:25660): (tetratricopeptide repeat domain 21B) This gene encodes a member of TTC21 family, containing several tetratricopeptide repeat (TPR) domains. This protein is localized to the cilium axoneme, and may play a role in retrograde intraflagellar transport in cilia. Mutations in this gene are associated with various ciliopathies, nephronophthisis 12, and asphyxiating thoracic dystrophy 4. [provided by RefSeq, Oct 2011]
TTC21B Gene-Disease associations (from GenCC):
  • nephronophthisis 12
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • asphyxiating thoracic dystrophy 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Jeune syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nephronophthisis 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 2-165873650-C-A is Benign according to our data. Variant chr2-165873650-C-A is described in ClinVar as [Benign]. Clinvar id is 331798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.315 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTC21BNM_024753.5 linkc.*1105G>T 3_prime_UTR_variant Exon 29 of 29 ENST00000243344.8 NP_079029.3
TTC21BXM_047445870.1 linkc.*1105G>T 3_prime_UTR_variant Exon 25 of 25 XP_047301826.1
TTC21BXM_011511871.4 linkc.*1105G>T 3_prime_UTR_variant Exon 24 of 24 XP_011510173.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTC21BENST00000243344.8 linkc.*1105G>T 3_prime_UTR_variant Exon 29 of 29 1 NM_024753.5 ENSP00000243344.7 Q7Z4L5-1

Frequencies

GnomAD3 genomes
AF:
0.239
AC:
36266
AN:
151800
Hom.:
5148
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0864
Gnomad AMI
AF:
0.356
Gnomad AMR
AF:
0.257
Gnomad ASJ
AF:
0.387
Gnomad EAS
AF:
0.129
Gnomad SAS
AF:
0.267
Gnomad FIN
AF:
0.264
Gnomad MID
AF:
0.404
Gnomad NFE
AF:
0.319
Gnomad OTH
AF:
0.289
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.239
AC:
36270
AN:
151918
Hom.:
5150
Cov.:
32
AF XY:
0.236
AC XY:
17544
AN XY:
74236
show subpopulations
African (AFR)
AF:
0.0862
AC:
3575
AN:
41452
American (AMR)
AF:
0.258
AC:
3931
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.387
AC:
1343
AN:
3470
East Asian (EAS)
AF:
0.128
AC:
662
AN:
5152
South Asian (SAS)
AF:
0.267
AC:
1285
AN:
4810
European-Finnish (FIN)
AF:
0.264
AC:
2780
AN:
10534
Middle Eastern (MID)
AF:
0.408
AC:
119
AN:
292
European-Non Finnish (NFE)
AF:
0.319
AC:
21647
AN:
67928
Other (OTH)
AF:
0.287
AC:
604
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1334
2668
4001
5335
6669
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
372
744
1116
1488
1860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.268
Hom.:
797
Bravo
AF:
0.233
Asia WGS
AF:
0.185
AC:
645
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Asphyxiating thoracic dystrophy 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nephronophthisis 12 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.94
DANN
Benign
0.76
PhyloP100
-0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6756388; hg19: chr2-166730160; API